Alternative approach to correction of uremic syndrome for patient with kidney tumour against a background of diabetes
Vol 79 No 2–3 (2018), Urology
Vol 79 No 2–3 (2018)

Alternative approach to correction of uremic syndrome for patient with kidney tumour against a background of diabetes

Urology
Published July 14, 2020
V.M. Lisovyi
Kharkov National Medical University Regional Medical Clinical Center of Urology and Nephrology named after V. I. Shapoval
N.M. Andonieva
Kharkov National Medical University Regional Medical Clinical Center of Urology and Nephrology named after V. I. Shapoval
M.M. Poliakov
Kharkov National Medical University Regional Medical Clinical Center of Urology and Nephrology named after V. I. Shapoval
O.A. Huts
Kharkov National Medical University Regional Medical Clinical Center of Urology and Nephrology named after V. I. Shapoval
M.Y. Dubovyk
Kharkov National Medical University Regional Medical Clinical Center of Urology and Nephrology named after V. I. Shapoval
S.M. Kolupaiev
Kharkov National Medical University
PDF (Українська)

Keywords

uremic syndrome
diabetes mellitus
kidney cancer
nephrectomy

How to Cite

Lisovyi, V., Andonieva, N., Poliakov, M., Huts, O., Dubovyk, M., & S.M. Kolupaiev, S. K. (2020). Alternative approach to correction of uremic syndrome for patient with kidney tumour against a background of diabetes. Experimental and Clinical Medicine, 79(2–3), 141-145. Retrieved from https://ecm.knmu.edu.ua/article/view/428
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Malignant kidney neoplasms in uremic patients is a relatively common type of tumors. The association of these diseases significantly worsens the prognosis for the patient, and if it is impossible to perform renal replacement therapy, inevitably leads to a fatal outcome. The article describes the observation of a patient with uremic syndrome against a background of diabetes mellitus with multiple vascular complications, in which the clear-celled kidney cancer was diagnosed. For a number of reasons, renal replacement therapy could not be performed. The nephrectomy performed in connection with the presence of the tumor significantly improved the patient's condition, reduced the manifestations of the nephrotic syndrome, slowed the progression of renal failure, allowed to postpone the need for renal replacement therapy.
PDF (Українська)

References

Clase C., Garg A., Kiberd М. (2002). Prevalence of low glomerular filtration rate in non-diabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). Am. Soc. Nephrol. vol. 13 (5), pp 1338–1349.

IDF Diabetes Atlas Eighth edition 2017 / International Diabetes Federation (2017). Available from: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas.html.

Herzog C.A., Asinger R.W., Berger A.K., Charytan D.M., Díez J., Hart R.G. [et al.] (2011). Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. vol. 80 (6), pp. 572–586.

Matas A.J., Simmons R.L., Kjellstrand C.M., Buselmeier T.J., Najarian J.S. (1975). Increased incidence of malignancy during chronic renal failure. Lancet. vol. 19 (1), pp. 883–886.

Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P. (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. vol. 18 (3), pp. 581–592.

Launay-Vacker V., Oudard S., Janus N. Gligorov J., Pourrat X., Rixe O. [et al.] (2007). Renal Insufficiency and Cancer Medications (IRMA) Study Group. Prevalence of renal insufficiency in cancer patients and implications for anti cancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer. vol. 110 (6), pp. 1376–1384.

Chow W.H., Dong L.M., Devesa S.S. (2010). Epidemiology and risk factors for kidney cancer. Nat. Rev. Urol. vol. 7 (5), pp. 245–257.

Noone A.M., Howlader N., Krapcho M. Miller D., Bishop K., Kosary C.L. [et al.] (eds) (april 2018) SEER Cancer Statistics Review 1975–2015. National Cancer Institute. Bethesda, MD. Available from: https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site.

Rathmell W.K., Godley P.A. (2010). Recent updates in renal cell carcinoma. Curr. Opin. Oncol. vol. 22 (3), pp. 250–256.

Garcia J.A., Cowey C.L., Godley P.A. (2009). Renal cell carcinoma. Curr. Opin. Oncol. vol. 21 (3), pp. 266–271.

Dulabon L.M., Lowrance W.T., Russo P. Huang W.C. (2010). Trends in renal tumor surgery delivery within the United State. Cancer. vol. 116, p. 2316.